About AN2 Therapeutics (ANTX)
AN2 Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing treatments for rare, chronic, and serious infectious diseases with high unmet needs. The Company is focused on advancing its first product candidate, epetraborole, a once... Read more
- USD17.19
- USD17.19
- USD16.28
- USD17.75
- 13.00%
- --
- 1.00
- 48.90k
- 513M
- 4.87
- 49.00%
Stock News
1 hour ago
Key Words: Paris mayor leaves Elon Musk’s social-media service, calling it a ‘gigantic global sewer’
MarketWatch
1 hour ago
NLS Pharmaceutics Announces Election of Additional Board Members
Yahoo
2 hours ago
Earnings Results: PDD’s stock rockets as Temu parent crushes estimates, sees revenue nearly double
MarketWatch
2 hours ago
Help Me Retire: Will my wife’s school pension and my military retirement pay reduce our Social Security? We’ll start collecting at 70.
MarketWatch
Unlock More Stock Analysis & Reports
Access to easy in-depth stock analysis and reports from Refinitiv with analyst estimates on share price movements.
